Patents Assigned to Dunhall Pharmaceuticals, Inc.
  • Publication number: 20010019817
    Abstract: An apparatus and method is disclosed for treating a tooth with an active agent such as a tooth whitening agent comprising a stint having an internal region defined by an internal surface. A plurality of indentations are formed in the internal surface for retaining the active agent to maintain the active agent in contact with the tooth when the stint is applied upon the tooth. The stint is molded from a sheet of plastic material with the indentations being formed by an abrading process such as abrasive blasting or the like.
    Type: Application
    Filed: February 21, 2001
    Publication date: September 6, 2001
    Applicant: Dunhall Pharmaceuticals, Inc.
    Inventor: Daniel H. Darnell
  • Patent number: 5575655
    Abstract: An apparatus and method is disclosed for treating a tooth with an active agent such as a tooth whitening agent comprising a stint having an internal region defined by an internal surface. A plurality of indentations are formed in the internal surface for retaining the active agent to maintain the active agent in contact with the tooth when the stint is applied upon the tooth. The stint is molded from a sheet of plastic material with the indentations being formed by an abrading process such as abrasive blasting or the like.
    Type: Grant
    Filed: October 17, 1994
    Date of Patent: November 19, 1996
    Assignee: Dunhall Pharmaceuticals, Inc.
    Inventor: Daniel H. Darnell
  • Patent number: 5356291
    Abstract: An apparatus and method is disclosed for treating a tooth with an active agent such as a tooth whitening agent comprising a stint having an internal region defined by an internal surface. A plurality of indentations are formed in the internal surface for retaining the active agent to maintain the active agent in contact with the tooth when the stint is applied upon the tooth. The stint is molded from a sheet of plastic material with the indentations being formed by an abrading process such as abrasive blasting or the like.
    Type: Grant
    Filed: January 26, 1993
    Date of Patent: October 18, 1994
    Assignee: Dunhall Pharmaceuticals, Inc.
    Inventor: Daniel H. Darnell
  • Patent number: 4990089
    Abstract: There is disclosed a process and a material for brightening teeth. The process comprises the construction of a splint around the tooth or teeth to be brightened, followed by the insertion within the splint of a brightening agent selected from one of many peroxide groups. The splint is constructed so that the splint is relatively liquid tight to the gingiva. The brightening agent is periodically renewed and can be mixed with various other agents to increase the nascent oxygen release aerating factors. In one embodiment, the peroxide that is used is a 10% solution of carbamide peroxide mixed with a water free gel.
    Type: Grant
    Filed: May 4, 1990
    Date of Patent: February 5, 1991
    Assignee: Dunhall Pharmaceuticals, Inc.
    Inventor: John R. Munro
  • Patent number: RE34196
    Abstract: There is disclosed a .Iadd.novel .Iaddend.process and a .[.material.]. .Iadd.composition .Iaddend.for brightening teeth.Iadd., together with a novel use of old compositions for brightening teeth. .Iaddend.The .Iadd.novel .Iaddend.process .Iadd.and use each comprises .Iaddend..[.comprises.]. the .[.construction.]. .Iadd.placing .Iaddend.of a splint around the tooth or teeth to be brightened, .[.followed by the insertion within the splint of.]. .Iadd.with .Iaddend.a brightening agent .[.selected from one of many peroxide groups.]. .Iadd.comprising a composition capable of sustained nascent oxygen release.Iaddend.. The splint is constructed so that the splint is relatively liquid tight .[.to the gingiva.].. .Iadd.Preferably, .Iaddend.the brightening agent is periodically renewed .Iadd.during the day .Iaddend.and can be mixed with various other agents to increase the nascent oxygen release .[.aerating factors.].. In one embodiment, the .[.perioxide.]. .Iadd.peroxide .Iaddend.
    Type: Grant
    Filed: August 7, 1991
    Date of Patent: March 16, 1993
    Assignee: Dunhall Pharmaceuticals, Inc.
    Inventor: John R. Munro